Key result
Levothyroxine replacement therapy for 6 months significantly improved aortic distensibility (from 3.8 to 5.7; P<0.001) and reversed adverse effects on diastolic left ventricular function.
Why the study?
Does levothyroxine replacement therapy improve ascending aortic elastic properties and diastolic LV function in patients with hypothyroidism?
Observational (n=66)
Does levothyroxine replacement therapy improve ascending aortic elastic properties and diastolic LV function in patients with hypothyroidism?
Levothyroxine replacement therapy reverses impaired ascending aortic elasticity and diastolic left ventricular dysfunction in patients with hypothyroidism.
Answers are grounded in this paper and cite their sources.
Supports levothyroxine effects on aortic and LV function in hypothyroidism; leaves open need for randomized confirmation before practice change.
BACKGROUND: We sought to clarify the possible role of elastic properties of the ascending aorta in the development of cardiac disease associated with hypothyroidism (HT). METHODS: A total of 37 patients with HT (age: 39.3 +/- 8.9 years) and 29 control subjects were studied. Ascending Aortic (Ao) diameter, Ao elastic indexes, strain (AoST), distensibility (AoD), stiffness index (AoSI), and pressure strain modulus were calculated from the echocardiographically derived Ao diameters. Myocardial performance index (MPI), E/A ratio, isovolumetric relaxation time (IVRT), deceleration time (DT) were measured by Doppler echocardiography to assess diastolic LV function. Patients were treated with levothyroxine and followed-up for 6 months. Thyroid function tests and echocardiographic measurements were repeated at the end of the study. RESULTS: AoD (cm2 dyn(-1) 10(-3)) and AoST (%) were significantly lower (3.8 vs. 6.1; P < 0.001, 7.4 vs. 12.6, P < 0.001; respectively), whereas AoSI was higher in HT patients (6.2 vs. 3.3; P < 0.001). After treatment, AoD and AoST were increased (5.7; P < 0.001 and 11.8; P < 0.001; respectively), whereas AoSI was decreased significantly (3.7; P < 0.001). Also, early/late mitral peak velocity ratio (Emax/Amax) was significantly lower in HT patients (1.19 vs 1.34; P < 0.01), whereas MPI was higher (0.52 vs. 0.42; P < 0.001). MPI showed a strong correlation with aortic root indexes [AoST (r =-0.61/P < 0.001); AoD, (r =-0.57/P < 0.002); AoSI, (r = 0.53/P < 0.005)] in the HT group. After 6 months of therapy, MPI significantly decreased P < 0.001) and E/A ratios were normalized (P < 0.001). CONCLUSIONS: Ao root functions have an important role on diastolic LV function. Levothyroxine replacement therapy can reverse all of these adverse effects of HT.
No takes yet. Share an insight, caveat, or question.
Özhan et al. (2005) conducted an observational in Hypothyroidism (n=66). Levothyroxine vs. Baseline (pre-treatment) was evaluated on Aortic distensibility (AoD) (p=<0.001). Levothyroxine replacement therapy for 6 months significantly improved aortic distensibility (from 3.8 to 5.7; P<0.001) and reversed adverse effects on diastolic left ventricular function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: